Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1993 1
1994 1
1995 2
1996 5
1998 2
2000 4
2001 1
2002 2
2009 1
2011 1
2016 1
2017 1
2018 1
2019 2
2020 4
2021 10
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
Shrotri M, Krutikov M, Palmer T, Giddings R, Azmi B, Subbarao S, Fuller C, Irwin-Singer A, Davies D, Tut G, Lopez Bernal J, Moss P, Hayward A, Copas A, Shallcross L. Shrotri M, et al. Among authors: krutikov m. Lancet Infect Dis. 2021 Nov;21(11):1529-1538. doi: 10.1016/S1473-3099(21)00289-9. Epub 2021 Jun 23. Lancet Infect Dis. 2021. PMID: 34174193 Free PMC article.
Screening for tuberculosis among high-risk groups attending London emergency departments: a prospective observational study.
Gupta RK, Lule SA, Krutikov M, Gosce L, Green N, Southern J, Imran A, Aldridge RW, Kunst H, Lipman M, Lynn W, Burgess H, Rahman A, Menezes D, Rahman A, Tiberi S, White PJ, Abubakar I. Gupta RK, et al. Among authors: krutikov m. Eur Respir J. 2021 Jun 24;57(6):2003831. doi: 10.1183/13993003.03831-2020. Print 2021 Jun. Eur Respir J. 2021. PMID: 33737408 Free PMC article.
The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis.
Krutikov M, Faust L, Nikolayevskyy V, Hamada Y, Gupta RK, Cirillo D, Mateelli A, Korobitsyn A, Denkinger CM, Rangaka MX. Krutikov M, et al. Lancet Infect Dis. 2022 Feb;22(2):250-264. doi: 10.1016/S1473-3099(21)00261-9. Epub 2021 Oct 1. Lancet Infect Dis. 2022. PMID: 34606768
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
Gupta RK, Calderwood CJ, Yavlinsky A, Krutikov M, Quartagno M, Aichelburg MC, Altet N, Diel R, Dobler CC, Dominguez J, Doyle JS, Erkens C, Geis S, Haldar P, Hauri AM, Hermansen T, Johnston JC, Lange C, Lange B, van Leth F, Muñoz L, Roder C, Romanowski K, Roth D, Sester M, Sloot R, Sotgiu G, Woltmann G, Yoshiyama T, Zellweger JP, Zenner D, Aldridge RW, Copas A, Rangaka MX, Lipman M, Noursadeghi M, Abubakar I. Gupta RK, et al. Among authors: krutikov m. Nat Med. 2020 Dec;26(12):1941-1949. doi: 10.1038/s41591-020-1076-0. Epub 2020 Oct 19. Nat Med. 2020. PMID: 33077958
43 results